2,003
Participants
Start Date
May 31, 2001
Primary Completion Date
August 31, 2006
Study Completion Date
September 30, 2006
PAL-40 Active
PAL-40 Placebo
New York Harbor HCS, New York
VA Medical Center, Bronx, The Bronx
VA Medical Center, Northport, Northport
VA Medical Center, Syracuse, Syracuse
VA Western New York Healthcare System at Buffalo, Buffalo
VA Pittsburgh Health Care System, Pittsburgh
VA Medical Center, DC, Washington D.C.
Hunter Holmes McGuire VA Medical Center, Richmond
North Florida/South Georgia Veterans Health System, Gainesville
VA Medical Center, Miami, Miami
West Palm Beach VA Medical Center, West Palm Beach
VA Medical Center, Bay Pines, Bay Pines
VA Medical Center, Birmingham, Birmingham
VA Medical Center, Memphis, Memphis
G.V. (Sonny) Montgomery VA Medical Center, Jackson, Jackson
VA Medical Center, Cleveland, Cleveland
VA Medical Center, Dayton, Dayton
VA Ann Arbor Healthcare System, Ann Arbor
John D. Dingell VA Medical Center, Detroit, Detroit
VA Medical Center, Minneapolis, Minneapolis
VA Medical Center, Kansas City MO, Kansas City
Southeast Veterans Healthcare System, New Orleans, New Orleans
VA North Texas Health Care System, Dallas, Dallas
Michael E. DeBakey VA Medical Center (152), Houston
VA Eastern Colorado Health Care System, Denver, Denver
VA San Diego Healthcare System, San Diego, San Diego
Health Economics Resource Center (HERC), Menlo Park, Menlo Park
VA Medical Center, Portland, Portland
VA Puget Sound Health Care System, Seattle, Seattle
VA Palo Alto Health Care System, Palo Alto
VA Connecticut Health Care System (West Haven), West Haven
Edward Hines, Jr. VA Hospital, Hines
Richard Roudebush VA Medical Center, Indianapolis, Indianapolis
VA Medical Center, Jamaica Plain Campus, Boston
Ralph H Johnson VA Medical Center, Charleston, Charleston
Zablocki VA Medical Center, Milwaukee, Milwaukee
VA Medical Center, San Juan, San Juan
Collaborators (1)
Pan American Laboratories
INDUSTRY
Abbott Diagnostics Division
INDUSTRY
US Department of Veterans Affairs
FED